Recently, pharmaceutical SaaS service provider Taimei Medical announced that it has completed the tens of millions of Class B round financing in June. The current round of financing was led by Arctic Light Ventures. The previous investors were Jingwei China and Kaifeng Ventures. After the completion of this round of financing, Taimei Medical will continue to expand the company's scale, increase product research and development efforts, improve the data processing center, and establish internal control departments such as risk control. According to the data of the Venture Capital Project Library, Taimei Medical is the full name of Jiaxing Taimei Medical Technology Co., Ltd., established in June 2013. It is a SaaS solution provider in the pharmaceutical industry, covering clinical research, pharmacovigilance and other fields, including Mobile-EDC. Electronic data acquisition system, Mobile-CTMS clinical trial project management system, Mobile-IWRS interactive response random system, drug safety management system, etc. Application of information technology, serving pharmaceutical research and development, speeding up research and development, reducing costs and improving efficiency. At present, Taimei Medical has been applied in more than 50 pharmaceutical companies and CRO companies, with more than 500 operating projects covering hundreds of studies including cancer, common diseases and rare diseases. More than 100,000 patients are included annually. Zhao Wei, founder of Taimei Medical, said that Taimei Medical mainly designs and develops mobile data collection tools, real-time and extensive data collection, greatly expanding the boundaries of clinical research, and fundamentally changing the traditional model of clinical research; At the same time, it provides services such as cloud storage, processing, and presentation of data through a remote, intensive mode. Zhao Wei said that Taimei Medical can achieve complete communication of data, create a completed data chain, and shorten the drug marketing cycle. According to the Venture Capital Times, Taimei Medical received the investment from Yuanhe Holdings Kaifeng Venture Capital in 2014. In February 2016, it obtained Jingyuan China's tens of millions of yuan A round of financing. Anesthesia Medical Co., Ltd. , https://www.trustfulmedical.com